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Introduction
Diabetes mellitus is characterized by chronic 
hyperglycemia with disturbances of carbohydrate, fat, and 
lipid metabolism resulting from defect in insulin secretion, 
insulin action, or both. The effects of diabetes mellitus 
include long term damage, dysfunction, and failure of 
various organs (1). It not only leads to hyperglycemia 
but also may cause hyperlipidemia, atherosclerosis, and 
hypertension (2).
Diabetes is a chronic metabolic disorder, which is 
considered as a major worldwide health problem. It 
is characterized by absolute or relative deficiency in 
insulin secretion and/or insulin action associated with 
chronic hyperglycemia and disturbances of carbohydrate, 
lipid, and protein metabolism. As a consequence 
of the metabolic derangements in diabetes, various 
complications including both macro- and micro-vascular 
dysfunctions develop (3).
In advanced stages of diabetes, metabolism of protein 
and lipid is also altered. Many factors like heredity, age, 
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Introduction: Diabetes mellitus is characterized by chronic hyperglycemia with disturbances of 
carbohydrate, fat, and lipid metabolism resulting from defect in insulin secretion, insulin action, 
or both. It not only leads to hyperglycemia but also may cause hyperlipidemia. Herbal medicines 
have always been considered as a healthy source of life. Although medicinal herbs and their 
derivatives have long been used for hyperlipidemia, their definite effects have not yet been proven 
by valid research. The aim of this study was to measure minerals in B. lycium fruit and to evaluate 
the effects of its ethanolic extract on lipid profile in diabetic rats. 
Methods: For this study 40 male Wistar rats were used and were divided into five equal groups. 
For induction of diabetes in animals, alloxan monohydrate was used. The animals were under 
treatment for 42 days. For healthy and diabetic control groups distilled water, for positive diabetic 
control metformin, for the fourth and fifth diabetic groups Berberis lycium extract in respectively 
200 and 600 mg/kg dose were used, daily. Blood samples were collected from heart and lipid 
profile was measured with autoanalyzer and HPLC. 
Results: The results of the study indicated that iron level in Berberis lycium fruit was considerably 
high. In diabetic rats administered with Berberis lycium fruit extract in 600 mg/kg dose, the lipid 
profile decreased significantly (p<0.05).
Conclusion: The present investigation showed that the Berberis lycium fruit extract alleviates lipid 
profile level and might be used efficiently in hyperlipidemia, especially in diabetic patients. It may 
also be beneficial in iron deficiency.
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obesity, diet, sex, sedentary life style, socioeconomic 
status, hypertension, and various stresses are involved in 
the etiology of diabetes mellitus (4).
Diabetes mellitus is a complex, multifarious group of 
disorders, which has reached epidemic proportions in the 
present century. The number of people affected by diabetes 
is estimated to be 366 million by year 2030 worldwide (5). 
Diabetes is a substantial contributor to the global burden 
of disease. Excess healthcare costs of diabetes are mainly 
due to the complications of cardiovascular diseases (6).
Diabetes mellitus type 2 is an important cardiovascular 
risk factor. A significant component of the risk associated 
with diabetes type 2 is thought to be due to lipid profile 
and elevated triglycerides. Chronic elevations of free fatty 
acids (FFA) induce insulin resistance and contribute to the 
lipid triad of diabetes. Therefore, reducing their levels is 
likely to ameliorate insulin resistance and to improve the 
lipid triad of diabetes (6,7).
Hyperlipidemia is a heterogeneous group of disorders 
characterized by an excess of lipids in the blood 
stream. High lipid levels can speed up a process called 
atherosclerosis that leads to cardiovascular disease and 
diabetes (8). Many studies have previously discussed the 
role of oxidative stress in atherosclerosis and there is 
now a consensus that atherosclerosis represents a state 
of heightened oxidative stress characterized by lipid and 
protein oxidation in the vascular wall (9). 
Cardiovascular diseases are the main causes of death 
or life-threatening morbidities throughout the world. 
Hyperlipidemia is a major risk factor for these disorders 
and is closely associated with development and progression 
of coronary atherosclerosis (8).
Since ancient times, people have used plants to treat their 
illnesses. Every day, the popularity of medicinal plants 
is increasing in the world. As it is increasingly believed 
now that traditional medicines have become more 
popular worldwide, there is growing evidence suggesting 
medicinal plants are unlimited resources of drugs (10). 
Therefore, it is rationale to search for new, safer medicinal 
drugs (5). Herbal medicines have always been considered 
as a healthy source of life and different experimental 
and clinical researches have shown promising effects 
for various conditions such as atherosclerosis, diabetes, 
cancer, infection, gastrointestinal and central nervous 
system disorders (11). Although medicinal herbs and 
their derivatives have long been used as a remedy for 
hyperlipidemia, their definite effects have not yet been 
proven by valid research (12). 
Nutraceuticals and functional foods have attracted 
considerable interest as potential alternative therapies 
for treatment of different cardiovascular disorders and 
insulin resistance. Efficacy of a combination of two 
types of Barberry extract in a sample of overweight, 
dyslipidemic patients at low cardiovascular risk was 
evaluated  and it was found to be safe and effective in 
improving lipid profile (13).
The Berberidaceae family (order Ranunculales), a member 
of the basal eudicots in the flowering plants, comprises 
15–17 genera of the flowering plants commonly called 
the barberry family and is apparently monophyletic. 
This family is distributed in the temperate regions of the 
northern hemisphere (14). Berberry is the largest genus in 
the family and contains about 450–500 species of deciduous 
or evergreen shrubs from 1 to 5 m tall with thorny shoots, 
native to the temperate and subtropical regions of Europe, 
Asia, Africa, and North and South America (15).
The genus has two important centers of diversity, 
Eurasia with about 300 species and South America with 
about 200 species. 
Twenty two alkaloids have been reported so far from root, 
stem leaves, and fruit of this plant, which are of medicinal 
importance. As a herbal remedy it has been peerless in 
serving human race since ancient times (16).
The genus includes several species in Iran, such as B. 
integerrima Bunge, B. crataegina DC, B. vulgaris L., 
B. orthobotrys Bienert ex, and B. lyceum. The plant B. 
vulgaris belongs to the Euro-Siberian floristic region and 
three other species are Irano-Turanian elements. The 
distribution range of B. orthobotrys is restricted to the 
Alborz Mountains and Kopetdagh-Khorasan (17,18).
Various parts of this plant including its root, bark, leaf, 
and fruit have long been used in folk medicine in Iran. 
In Iranian traditional medicine several properties, such as 
antibacterial, antipyretic, antipruritic, and antiarrhythmic 
activities for different parts of B. vulgaris have been 
reported with unknown mechanisms of actions (19,20). 
There are phenolic compounds in different parts of 
berberis including barberry fruit (20).
The aim of this study was to measure minerals in B. lycium 
fruits and to evaluate the effects of its ethanolic extract on 
levels of cholesterol, TG, high density lipoprotein (HDL), 
low density lipoprotein (LDL), very low density lipoprotein 
(VLDL), and malondialdehyde (MDA) in diabetic rats. 
Materials and Methods 
Animals
For this study, healthy adult male Wistar rats  (8 weeks old), 
weighing 250-275 g, were purchased from Central Animal 
House, Shahid Beheshti University of Medical Sciences. 
The animals were kept in individual plastic cages with 
stainless steel covers (4 animals per cage) and were kept at 
temperature of 25 ± 2 °C, humidity of 60 ± 5%, and 12-h 
dark/light cycle. All rats had free access to water and food 
and fasted overnight before blood and tissue taking (21). 
The experiments were conducted in accordance with the 
Guidelines for the Care and Use of Laboratory Animals 
and the study was approved by Shahrekord University of 
Medical Sciences Ethics Committee.
Induction of diabetes 
Prior to diabetes induction, a group of eight rats was 
isolated and kept as control in two cages of four each. For 
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other animals, alloxan monohydrate was used to induce 
diabetes mellitus. Alloxan (Sigma Co., USA), dissolved in 
cool saline, was injected through back of the neck, with a 
dose of 125 mg/kg body weight (BW). The three injections 
of alloxan were done for each animal in three consecutive 
days. The alloxan-induced diabetes was confirmed by 
determining the serum glucose levels in the blood taken 
from the animals’ tails using glucosometer (22). Animals 
with blood glucose above 300 mg/dl were considered 
diabetic and included in the study. For the animals in 
control group distilled water was injected subcutaneously.
Experimental design 
In this experiment research, 40 male Wistar rats were 
used. Animals were divided into five equal groups, with 8 
rats in each group, as follows: 
Group I, healthy control rats; group II, diabetic control 
rats; group III, positive control rats under metformin 
treatment (150 mg/kg); group IV, diabetic rats under 
treatment with Berberis lycium fruit extract (200 mg/
kg); and group V, diabetic rats with Berberis lycium fruit 
extract (600 mg/kg). Extract fruits and drug were given 
orally by gavage for 42 days.
Preparation of the plant 
Berberis lycium fruits was purchased from reputable stores 
in Shahrekord. The genus and species of the Berberis 
lycium was confirmed by the botanists Agriculture 
Research Center of Shaherkord. The purchased samples 
were prepared and kept in Medical Plants Research Center 
Herbarium of Shahrekord University of Medical Sciences, 
Shahrekord, Iran.
Extraction
For extraction, 250 g dried Berberis lycium fruit at one 
balloon was macerated with 700 ml distilled water 
for 72 hours. The resulting solution was filtered and 
then the alcohol existing in the one solutions was 
evaporated by rotary machine (23). Then, it was dried in 
incubator at 37 °C. 
Animals’ treatment
The animals were under treatment for 42 days. For healthy 
and diabetic control groups distilled water, for positive 
diabetic control metformin, for the fourth and fifth 
diabetic groups Berberis lycium extract in respectively 200 
and 600 mg/kg dose was used daily. 
Collection and storage of samples
After 42 days of the study, the animals were anesthetized 
by chloroform blood samples were collected heart. Serum 
(plasma) was isolated by centrifugation of blood samples 
at 3000 rpm for 10 minutes. All samples were stored 
at 4 °C until analysis.
Biochemical analysis
Lipid profile was measured using a diagnostic commercial 
kits (Pars Azmoon, Iran), and total cholesterol, 
triglyceride, LDL, HDL, VLDL using autoanalyzer and 
MDA using HPLC (24). 
Statistical analysis
The data were analyzed by ANOVA and Tukey tests using 
SPSS software version 16.0 to determine the statistical 
significance of data obtained from study groups.  P<0.05 
was considered significant. 
Results
The results of the study indicated that Iron (Fe) level in 
Berberis lycium fruit was considerably high (Table 1) and 
Berberis lycium fruit extract reduced the plasma lipid 
levels and reversed to normal levels in rats (Table 2).
Total cholesterol, triglyceride, LDL, MDA, and VLDL 
values increased significantly (p<0.05) in diabetic rats and 












Mg % Ca % K % P % N %
Berberis lycium 58.67 33.50 27.50 2649.99 1.67 0.541 0.155 1.056 0.280 1.326
Table 2.  Lipid profile and malondialdehyde in groups following 42 days usage of Berberis lycium fruit extract or metformin.
Groups Total chol.(mg/dl) TG  (mg/dl) LDL (mg/dl) HDL (mg/dl) VLDL (mg/dl) MDA (µM)
Group 1 82.00±3.02 93.25±3.08 17.87±0.29 76.37±3.28 18.65±0.61 5.28±0.30
Group 2 118.50±5.15 135±2.90 27.50±0.53 40.62±2.03 27.05±0.58 19.08±2.39
Group 3 104.25±4.33 84.00±2.84 22.75±0.79 58.87±3.56 16.80±0.56 18.99±1.16
Group 4 101.25±5.08 116.75±1.30 22.37±1.13 37.62±2.24 23.35±0.26 19.15±0.90
Group 5 84.00±5.09 100.00±4.66 21.12±0.93 48.00±0.56 20.00±0.93 10.73±0.42
Group I, control rats; group II, Alloxan-induced diabetic control rats; group III, diabetic rats given solution of metformin in water (150 mg/kg); group IV, 
diabetic rats with Berberis lycium fruit extract (200 mg/kg); group V, diabetic rats with Berberis lycium fruit extract (600 mg/kg).
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HDL value decreased significantly compared with control 
rats (p<0.05) (Table 2).
In diabetic rats administered with Berberis lycium fruit 
extract in 600 mg/kg dose, the total cholesterol, triglyceride, 
LDL, MDA and VLDL values decreased significantly 
(p<0.05) and HDL value decreased significantly compared 
with diabetic control rats (p<0.05) (Table 2).
Discussion
In the present study it was observed that extract of Berberis 
lycium fruit had  antihyperlipidemic effect in diabetic rats, 
consistent with the results reported for alloxan-induced 
diabetic rabbits (19).
In this study, iron in Berberis lycium was high. In patients 
with thalassemia, it is recommended that more attention 
be paid in consuming Berberis lycium.
Berberine is the alkaloid of barberry. Oral administration 
of berberine in 32 hypercholesterolemic patients for three 
months reduced serum cholesterol by 29%, triglycerides 
by 35%, and LDL-cholesterol by 25%. Treatment of 
hyperlipidemic hamsters with berberine, reduced serum 
cholesterol by 40% and LDL-cholesterol by 42%, with 
a 3.5-fold increase in hepatic low-density lipoprotein 
receptor (LDLR) mRNA and a 2.6-fold increase in hepatic 
LDLR protein (25). The results of this study showed that 
barberry’s  extract reduced lipid profile, consistent with 
those of  Fattahi et al. study (20). 
Oral administration of Berberis extract and berberine 
to normal and experimental diabetic rats produced a 
significant reduction in blood glucose levels within 3–7 
days of treatment. Significant effects were also observed 
on the glucose tolerance, glycosylated hemoglobin, 
serum lipid profiles, and body weight of experimental 
animals (26). Some studies indicated that berberine 
exerted protective effects on cardiac dysfunction induced 
by hyperglycemia and hypercholesterolemia through 
alleviating cardiac lipid accumulation and promoting 
glucose transport (27).
A study demonstrated that Berberis lycium root bark had 
anti hyperlipedemic effect on alloxanized rabbits and 
decreased total cholesterol, triglycerides, and LDL while 
it increased the HDL level in alloxan-induced diabetic 
rabbits, partially consistent with our findings. Another 
study also showed that Berberis lycium could have 
antihyperlipidemic effect (19).
Aqueous extract of Berberis vulgaris fruit at amount 
of 3.5 and 7.5% of drinking water did not exhibit the 
hypoglycemic and hypolipidemic effects in streptozotocin-
diabetic rats during a 6-week treatment. However, the 
usage of barberry fruit in traditional medicine for the 
treatment of diabetes should be further studied (28). 
In this study the extract has been poured into water and 
it is not obvious how much extract has been received 
by animals and how much it has been affected by 
light and environment.
A study showed the beneficial use of this extract in 
traditional medicine, although the total extract had 
no clear superiority over well-known sulfonylurea 
drugs. Berberis integerrima aqueous extract showed 
antiglycemic, antilipidemic, and antioxidant effects in 
alloxan-induced diabetic rats (29), in agreement with the 
results of our study. 
Various pharmacological studies reported support 
Berberis lycium traditional use and may be useful in the 
development of some commercial drugs. Moreover, the 
nutritional properties such as high content of vitamins, 
minerals, and anthocyanin of Berberis lycium have added 
to its value.  The fruits of the plant are also very nutritious 
and rich in vitamins, minerals, antioxidants, anthocyanin, 
etc. (30), which is somehow consistent with our study. 
The aim of the present study was to evaluate the effects 
of extract fruit Berberis lycium on various lipid profiles 
in alloxan-induced diabetic rats. Oral administration 
of 200 mg/kg and 600mg/kg extract fruit of Berberis 
lycium for six weeks resulted in significant reduction in 
total cholesterol, triglyceride, and LDLs levels. Berberis 
lycium treatment increased the levels of HDLs. Thus, our 
investigation clearly shows that extract fruit of Berberis 
lycium has antihyperlipidemic effect.
Conclusion
The present investigation showed that the Berberis lycium 
fruit extract reduced the plasma lipid levels and reversed to 
normal levels in rats. Thus, our investigation clearly shows 
that extract fruit of Berberis lycium has antihyperlipidemic 
effect in hyperlipidemic patients and might be useful in 
these patients. It may also be useful in iron deficiency.
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